Dow Chemical Company’s Bristol-Myers Squibb BMY Stock Holding History

Dow Chemical Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-62,000	Closed	-$3.67M	–	33
2015 Q3	$3.67M	Sell	62,000 -10,000	-14%	-$634K	0.31%	38
2015 Q2	$4.79M	Hold	72,000	–	–	0.44%	30
2015 Q1	$4.64M	Buy	72,000 +7,000	+11%	+$438K	0.41%	31
2014 Q4	$3.84M	Buy	+65,000	New	+$3.67M	0.34%	35

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Dow Chemical Company's BMY Position: Q4 2015 in Review

Dow Chemical Company sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 62,000 shares — an estimated $3.67M sold.

Dow Chemical Company first reported a position in BMY in Q4 2014 and held it in 4 quarters. The position peaked at $4.79M in Q2 2015. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Dow Chemical Company reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
Dow Chemical Company sold 62,000 Bristol-Myers Squibb shares in Q4 2015, an estimated $3.67M.
Dow Chemical Company first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 4 quarters.
Dow Chemical Company's Bristol-Myers Squibb position peaked at $4.79M in Q2 2015.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Dow Chemical Company's 13F filing for Q4 2015, filed 16 Feb 2016.